
|Articles|April 1, 2004
- Volume 0 0
Asthma Has a Role in Dental Health
Advertisement
Published reports have indicated that asthma and tooth decay are among the major causes of school absenteeism in the United States. Children with asthma have a significantly higher rate of decayed, missing, and filled teeth, in the primary and permanent teeth. Adults and children with asthma may require a more aggressive dental-caries?prevention protocol, once asthma is diagnosed. Individuals with asthma may be more susceptible to the following oral-health changes:
- Increased rate of caries development due to prolonged use of beta2 agonist inhalers and asthma medications that contain sugar
- Reduced salivary flow because of inhaler use
- Increased likelihood of oral tissue changes
- Increased levels of gingivitis and gum disease
Dental experts have issued the following tips for proper dental care for asthmatics:
- Make frequent dental visits to prevent gum disease and cavities
- Take caries-prevention measures by following a good home care routine
- Update the dentist about changes in medications, date of last asthma attack, last emergency room visit because of asthmatic complications, and factors that cause an asthmatic reaction
- Take preoperative medications, and bring the medications to the dentist's office
Articles in this issue
over 22 years ago
RxPRODUCT NEWS PROFILE: Caduetover 22 years ago
COMPOUNDING HOTLINEover 22 years ago
Case Studiesover 22 years ago
Buddies Are Good for the Heartover 22 years ago
Low-Fat Diet Shows Promise for Prostate Cancerover 22 years ago
Rage Is Connected to Stroke Riskover 22 years ago
InnoLetover 22 years ago
Colace/Peri-Colaceover 22 years ago
TampAlerTover 22 years ago
Low Testosterone Is Linked with Alzheimer's DiseaseAdvertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
2
Beyond Prescription Volume: Measuring the Pharmacist’s Value
3
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


